1. $MGNX Takeda MGD010 buy-in Dec. 1Q16&4 DARTs R&D; $JNJ MGD011 Recruiting; Servier MGA271 buy-in Dec. Eo15&MGD007 buy-in Dec. Eo17 (2/2)

  2. $MGNX Partner M/S s: $PFE p-cadherin x CD3 DART to Clin 1H16; Boeh. Ing. preclin AI DARTs to Clin anytime; $GILD (unknown); (1/2)

  3. http://cancerimmunolres.aacrjournals.org/content/early/2015/06/27/2326-6066.CIR-15-0100.full.pdf Good anti-B7-H3 find frm @zDonShimoda -Daichii-Sankyo also pursuing,but $MGNX data1st/more adv

  4. MacroGenics VP Lynn Cilinski Sells $257,115 in $MGNX http://www.marketbeat.com/stocks/NASDAQ/MGNX/?RegistrationCode=SocialMedia-direct&DefaultTab=Insider

  5. MacroGenics SVP Jon Marc Wigginton Sells $185,750 in $MGNX http://www.marketbeat.com/stocks/NASDAQ/MGNX/?RegistrationCode=SocialMedia-direct&DefaultTab=Insider

  6. Biotechs in my hometown of Rockville, MD- $GSK $RNN $NVAX $MGNX $XON $UTHR

  7. Insider Transaction: $MGNX Automatic Sale at $38.07 per share of 6497 shares by Officer Bonvini Ezio on 2015-06-30.

  8. Insider Transaction: $MGNX Automatic Sale at $37.15 per share of 6921 shares by Officer Cilinski Lynn on 2015-07-01.

  9. Insider Transaction: $MGNX Automatic Sale at $37.15 per share of 5000 shares by Officer Wigginton Jon Marc on 2015-07-01.

  10. Senior VP of MACROGENICS INC just cashed-in 6,097 options http://www.conferencecalltranscripts.org/4/summary/?id=1815803 $MGNX

  11. $MGNX: New Insider Transaction on MGNX by Sr VP, Clinical Wigginton Jon Marc: http://insideri.com/1587487_000114036115026266_0001140361-15-026266

  12. Senior VP of MACROGENICS INC just cashed-in 6,497 options http://www.conferencecalltranscripts.org/4/summary2/?id=1815799 $MGNX

  13. Senior VP of MACROGENICS INC just cashed-in 13,054 options http://www.conferencecalltranscripts.org/4/summary2/?id=1815790 $MGNX

  14. $MGNX http://www.sugarconebiotech.com/?cat=517 Reviewing MGA271 site pic&articles(Nature,AACR& @PDRennert SugarCone&Imm.Slides)re:B7-H3&Cautiously optimistic

  15. @Think4self $OMER all those that followed my short idea have made over 15% since Friday. Learn to short. $TGTX $MGNX $DVAX $ECYT

  16. $MGNX ouch

  17. Trade-Ideas: Macrogenics (MGNX) Is Today s Weak On High Relative Volume Stock $MGNX http://www.thestreet.com/story/13205502/1/trade-ideas-macrogenics-mgnx-is-todays-weak-on-high-relative-volume-stock.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  18. $MGNX what s up with the drop today?

  19. Extremely impressed by $MGNX pps strength this last week-May not be able to re-establish swing...Considering LT shares,def. alright w/that.

  20. $MGNX $KPTI $DVAX holding up well. $LBIO came back nicely. $EPZM entry worked out great. $XOMA not so much. Trying to add to $TTOO pos.<$16.

  21. @Think4self $STML high chance of a bounce. Low float names could really go down and stay down long, so be careful. $VSTM $OMED $MGNX $IDRA

  22. $MGNX 3Q15:MGAH22 PHIII&MGA271+Keytruda start,MGA271 SA data@ESMO-2H15:MGD009 start-4Q15:MGAH22 Gastro combo start,EORTC-AACR preclin data.

  23. $MGNX $TGTX $SRNE $KPTI $LBIO $DVAX $TTOO $CEMP $FGEN Shouldn t be any volatility shortage this wk(w/Grexit&PuertoRico)as we enter 3Q 15-GL!

  24. $MGNX MGA271 (- s): No clin. data to date, heavy comp.&unknown biology w/in chkpnt inhib. fam., Safety could mean <clin. activity.

  25. $MGNX MGA271(+ s): FC Optimization, Derived frm CSC platform, most advanced&a novel trgt(B7-H3), ~safe, chkpnt inhib fam., Servier prtnr.